Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents)

Adult Stem Cells and the Clinical Arena: Are we Able to Widely Use this Therapy in Patients with Chronic Limbs Arteriopathy and Ischemic Ulcers without Possibility of Revascularization?
pp. 99-108(10)
Authors: Casamassimi, Amelia; Grimaldi, Vincenzo; Infante, Teresa; Al-Omran, Mohammed; Crudele, Valeria; Napoli, Claudio

Treating Depression in Coronary Artery Disease and Chronic Heart Failure: What's new in using Selective Serotonin Re-Uptake Inhibitors?
pp. 109-115(7)
Authors: Ioannis, Paraskevaidis; John, Palios; John, Parissis; Gerasimos, Filippatos; Maria, Anastasiou-Nana

Dabigatran - A New Chapter in Anticoagulation
pp. 116-123(8)
Authors: Ahmed, Shameer; Levin, Vadim; Malacoff, Robert; W. Martinez, Matthew

PPAR- γ Agonist in Treatment of Diabetes: Cardiovascular Safety Considerations
pp. 124-134(11)
Authors: Abbas, Aamer; Blandon, Jimena; Rude, Jennifer; Elfar, Ahmed; Mukherjee, Debabrata

Pain Management in Hematological Patients with Major Organ Dysfunctions and Comorbid Illnesses
pp. 135-147(13)
Authors: Niscola, Pasquale; Tendas, Andrea; Giovannini, Marco; Scaramucci, Laura; Cupelli, Luca; Ferrannini, Michele; Antonio Brunetti, Gregorio; Bondanini, Francesco; Palumbo, Roberto; Perrotti, Alessio; Romani, Claudio; Cartoni, Claudio; Efficace, Fabio; de Fabritiis, Paolo

Does A Subclinical Cardiotoxic Effect of Clozapine Exist? Results from a Follow-up Pilot Study
pp. 148-153(6)
Authors: Rostagno, Carlo; Domenichetti, Sandro; Franco Gensini, Gian

PF-04886847 (an Inhibitor of Plasma Kallikrein) Attenuates Inflammatory Mediators and Activation of Blood Coagulation in Rat Model of Lipopolysaccharide (LPS) - Induced Sepsis
pp. 154-166(13)
Authors: Kolte, D.; W. Bryant, J.; W. Gibson, G.; Wang, J.; Shariat-Madar, Z.

Microvascular Diseases: Is A New Era Coming?
pp. 167-183(17)
Authors: Wiernsperger, N.; R. Rapin, J.